Last reviewed · How we verify

NCT03837041: PROPRIO_TPG

Evaluation of Proprioception

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Reconditioning Proprioception in Proprioceptive Disorders in 71 participants. Completed in 31 December 2021.

Timeline
1 March 2017
Primary endpoint
31 July 2021
31 December 2021

Quick facts

Lead sponsorIstituto Ortopedico Rizzoli
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment71
Start date1 March 2017
Primary completion31 July 2021
Estimated completion31 December 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituto Ortopedico Rizzoli — full company profile →

Who can join

Adults 45 to 75, any sex, with Proprioceptive Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The osteoarthritis (OA) is a chronic and degenerative disease which brings articular cartilage degeneration. As a consequence, balance and proprioception could be dangerously reduced after total knee arthroplasty. Several studies demonstrated the correlation between OA, proprioception reduction and increased risk of falling. The aim of this study is to evaluate the proprioception improvement in patients with total knee arthroplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Proprioceptive Disorders

Currently open trials in the same condition.

Other Istituto Ortopedico Rizzoli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03837041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing